{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:58:04Z","timestamp":1793908684873,"version":"4.8.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.mehy.2020.109573","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:36:25Z","timestamp":1579520185000},"page":"109573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Reducing the progression of Alzheimer\u2019s disease in Down syndrome patients with micro-dose lithium"],"prefix":"10.1016","volume":"137","author":[{"given":"Garrick A.","family":"Priebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Kanzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mehy.2020.109573_b0005","first-page":"8","article-title":"Deaths: leading causes for 2014","volume":"65","author":"Heron","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.mehy.2020.109573_b0010","unstructured":"Keene CD, Montine TJ, Kuller LH. Epidemiology, pathology, and pathogenesis of Alzheimer disease UpToDate, retrieved August 26, 2019 from https:\/\/www.uptodate.com\/contents\/epidemiology-pathology-and-pathogenesis-of-alzheimer-disease; 2018."},{"issue":"3","key":"10.1016\/j.mehy.2020.109573_b0015","first-page":"353","article-title":"Alzheimer\u2019s disease in Down syndrome","volume":"1","author":"Head","year":"2012","journal-title":"Eur J Neurodegener Dis"},{"issue":"3","key":"10.1016\/j.mehy.2020.109573_b0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0019-5545.37325","article-title":"Lithium use in special populations","volume":"49","author":"Mohandas","year":"2007","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.mehy.2020.109573_b0025","unstructured":"Stovall J. Bipolar mania and hypomania in adults: choosing pharmacotherapy UpToDate, retrieved October 5, 2019, from https:\/\/www.uptodate.com\/contents\/bipolar-mania-and-hypomania-in-adults-choosing-pharmacotherapy; (2019)."},{"issue":"5","key":"10.1016\/j.mehy.2020.109573_b0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/11599180-000000000-00000","article-title":"Does lithium prevent Alzheimer\u2019s disease?","volume":"29","author":"Forlenza","year":"2012","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.mehy.2020.109573_b0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/1567205013666160219113112","article-title":"The putative use of lithium in Alzheimer\u2019s disease","volume":"13","author":"Morris","year":"2016","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"10.1016\/j.mehy.2020.109573_b0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.mehy.2020.109573_b0045","first-page":"104","article-title":"Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer\u2019s disease","volume":"10","author":"Marielza","year":"2013","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"10.1016\/j.mehy.2020.109573_b0050","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/npp.2010.41","article-title":"Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study","volume":"35","author":"Lyoo","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.mehy.2020.109573_b0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium and risk for Alzheimer\u2019s disease in elderly patients with bipolar disorder","volume":"190","author":"Nunes","year":"2007","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2020.109573_b0060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mrdd.20159","article-title":"Psychiatric and behavioral disorders in persons with Down syndrome","volume":"13","author":"Dykens","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719312332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719312332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:20:06Z","timestamp":1759692006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719312332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":12,"alternative-id":["S0306987719312332"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109573","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing the progression of Alzheimer\u2019s disease in Down syndrome patients with micro-dose lithium","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109573"}}